Rheumatologist

  • Placeholder

    ALKALINE PHOSPHATASE (ALP) ISOENZYMES

    0 out of 5

    This assay is useful for diagnosis and treatment of liver, bone, intestinal and parathyroid diseases. It determines the tissue source of increased Alkaline Phosphatase activity in serum. It is specially useful for differentiating between liver and bone sources of elevated Alkaline Phosphatase.

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Sample by Thu 9 am; Report Next day

  • Placeholder

    ALKALINE PHOSPHATASE, BONE-SPECIFIC; BSAP

    0 out of 5
  • Placeholder

    ANTI – ds DNA ANTIBODY, CRITHIDIA IFA IN DILUTIONS

    0 out of 5

    ds-DNA Antibody is detected in patients with active SLE and approximately 20% of patients with Mixed connective tissue disease.

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Sample Daily by 11 am; Report Next day

  • Placeholder

    ANTI – ds DNA ANTIBODY, EIA

    0 out of 5

    ds-DNA Antibody is detected in patients with active SLE and approximately 20% of patients with Mixed connective tissue disease.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Sample by Mon through Sat 9 am; Report Same day

  • Placeholder

    ANTI – ss DNA ANTIBODY

    0 out of 5

    This antibody is found in 15–20% of patients with Systemic LE.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

  • Placeholder

    ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP

    0 out of 5

    Anti CCP is useful in diagnosing Rheumatoid arthritis and entities that may potentially be confused with Rheumatoid arthritis that are rheumatoid factor positive.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    ANTI ds DNA ANTIBODY, CRITHIDIA IFA

    0 out of 5

    ds-DNA Antibody is detected in patients with active SLE and approximately 20% of patients with Mixed connective tissue disease.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Sample Daily by 11 am; Report Same day

  • Placeholder

    ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) END POINT TITRE

    0 out of 5

    ANA is useful in the diagnosis of patients with autoimmune diseases such as SLE, Mixed connective tissue disease, Rheumatoid arthritis, Sjogren’s syndrome, Progressive systemic sclerosis and CREST syndrome. The incidence of low titre ANA positivity increases with age in normal individuals. Many drugs like Hydralazine and Procainamide may induce ANA production.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Sample Daily by 11 am; Report Next Day

  • Placeholder

    ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) REFLEX TO ENA PROFILE

    0 out of 5

    ANA is useful in the diagnosis of patients with autoimmune diseases such as SLE, Mixed connective tissue disease, Rheumatoid arthritis, Sjogren’s syndrome, Progressive systemic sclerosis and CREST syndrome. The incidence of low titre ANA positivity increases with age in normal individuals. many drugs like Hydralazine and Procainamide may induce ANA production.

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Sample Mon through Sat by 11 am; Report Next day

  • Placeholder

    ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), EIA

    0 out of 5

    ANA is useful in the diagnosis of patients with autoimmune diseases such as SLE, Mixed connective tissue disease, Rheumatoid arthritis, Sjogren’s syndrome, Progressive systemic sclerosis and CREST syndrome. The incidence of low titre ANA positivity increases with age in normal individuals. many drugs like Hydralazine and Procainamide may induce ANA production.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample Daily by 9 am; Report Same day

  • -8%
    Diagnostic Centre in Pune

    ARTHRITIS PANEL 1

    0 out of 5
    2,500.00 2,300.00
  • -3%
    Placeholder

    ARTHRITIS PANEL 2

    0 out of 5
    3,200.00 3,100.00
  • -20%
    Diagnostic Centre in Pune

    ARTHRITIS PANEL BASIC

    0 out of 5
    2,000.00 1,600.00
  • Placeholder

    CALCIUM, IONIZED

    0 out of 5

    Ionized calcium provides a more physiologically accurate assessment of calcium especially in the presence of high protein concentrations, hyperparathyroidism and hypoparathyroidism.

    • Test Type:

      Blood

    • Pre-test Information:

      Overnight fasting is mandatory

    • Report Delivery:

      Daily

  • Placeholder

    CALCIUM, SERUM

    0 out of 5
  • Placeholder

    CENTROMERE ANTIBODY

    0 out of 5

    Centromere antibodies occur primarily in patients with CREST syndrome but may also be seen in some patients with Primary biliary cirrhosis, Rheumatoid arthritis and LE. This assay is used as an aid in the diagnosis of CREST syndrome and for evaluating patients with clinical presentation compatible with Systemic sclerosis.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    DPYD (DEOXYPYRIDINOLINE), URINE

    0 out of 5

    DPYD is formed during collagen maturation in bone and is released during bone resorption. Approximately 40% is found free in urinary excretions and 60% is bound to small peptides. DPYD Free is a sensitive and specific marker of bone resorption.

    • Pre-test Information:

      First morning urine sample recommended. Wrap the container in aluminium foil / dark paper. If used for monitoring therapy , urine should be collected at the same time on each occasion as for the baseline specimen.

    • Report Delivery:

      Sample by Mon 4 pm; Report Same day

  • Placeholder

    EXTRACTABLE NUCLEAR ANTIGENS (ENA), QUALITATIVE PROFILE

    0 out of 5

    This is a qualitative assay for sreening and identification of specific IgG autoantibodies against Extractable Nuclear Antigens in human serum. It aids in the diagnosis of certain Systemic Rheumatic diseases.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Mon through Sat by 9 am; Report Same day

  • Placeholder

    EXTRACTABLE NUCLEAR ANTIGENS (ENA), QUANTITATIVE PROFILE

    0 out of 5

    This is a quantitative assay for quantifying specific IgG autoantibodies against Extractable Nuclear Antigens in human serum. It aids in the diagnosis of certain Systemic Rheumatic diseases.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

    • Components:

      7

  • Placeholder

    HISTONE ANTIBODIES

    0 out of 5

    Histone antibody is present in 80-95% patients with Drug induced SLE, 20-50% patients with Idiopathic SLE and infrequently in patients with other autoimmune connective tissue diseases.

    • Pre-test Information:

      Overnight fasting is preferred.

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

  • Placeholder

    HLA – B27, QUALITATIVE PCR

    0 out of 5

    Approximately 8% of the normal population carries the HLA B27 antigen. It is present in Ankylosing spondylitis (89%), Reiter’s syndrome (79%) & Juvenile Rheumatoid arthritis (42%).

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 9 am; Report Same day

  • Placeholder

    HLA-B27, FLOW CYTOMETRY

    0 out of 5

    HLA B 27 positivity is associated with Ankylosing spondylosis and other diseases like Reiter’s syndrome, Anterior uveitis, Salmonella/Yersinia/ Psoriatic/ Juvenile Chronic Arthritis, Spondylitis with Inflammatory Bowel Disease.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 9 am; Report Same day

  • Placeholder

    HYPERCALCEMIA PANEL 1

    0 out of 5

    Hypercalcemia can be asymptomatic or can be a manifestation of serious illness like malignancy. Hyperparathyroidism is a frequent cause of asymptomatic hypercalcemia. Other causes of hypercalcemia are vitamin D related, associated with high bone turnover and renal failure.

    • Pre-test Information:

      Sample to be collected between 8-10 a.m. Overnight fasting is preferred.

    • Report Delivery:

      Daily

  • Placeholder

    HYPERCALCEMIA PANEL 2

    0 out of 5

    Hypercalcemia can be asymptomatic or can be a manifestation of serious illness like malignancy. Hyperparathyroidism is a frequent cause of asymptomatic hypercalcemia. Other causes of hypercalcemia are vitamin D related, associated with high bone turnover and renal failure. Vitamin D associated hypercalcemia can be due to excessive ingestion or abnormal metabolism of the vitamin.

    • Pre-test Information:

      Sample to be collected between 8-10 a.m. Overnight fasting is preferred.

    • Report Delivery:

      Daily

  • Placeholder

    Jo-1 ANTIBODY

    0 out of 5

    Jo-1 antibodies are a marker of Polymyositis & occur most commonly in Myositis patients who also have Interstitial lung disease. The antibodies are detected in 50% patients with Interstitial pulmonary fibrosis & Symmetrical polyarthritis

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    MYOSITIS PROFILE

    0 out of 5

    The detection of Myositis specific autoantibodies (MSAs) is essential in the diagnosis of autoimmune myositis. MSAs are directed against cytoplasmic or nuclear components involved in key regulatory intracellular processes including protein synthesis, translocation and gene transcription. The striking association between unique serological profiles and distinct clinical phenotypes suggests that target autoantigens may play a role in disease induction and propagation

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Thu 9 am; Report Same day

  • Placeholder

    PCNA (PROLIFERATING CELL NUCLEAR ANTIGEN), ANTIBODY

    0 out of 5
  • -33%
    Diagnostic Centre in Pune

    PHOSPHORUS, SERUM

    0 out of 5
    240.00 160.00
  • Placeholder

    POLARIZING MICROSCOPY, BODY FLUIDS

    0 out of 5

    This test is used to detect crystals in body fluids

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Daily by 2 pm; Report Same day

  • Placeholder

    RHEUMATOID ARTHRITIS PANEL

    0 out of 5

    Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. Serum antibodies to Cyclic citrullinated peptides (Anti CCP) are now recognised to be a valuable marker of diagnostic and prognostic significance. ANA’s occur both in systemic and organ specific autoimmune diseases showing positivity in Rheumatoid arthritis. There is incremental value in testing for presence of both Rheumatoid factor (RF) and Anti CCP as some patients with RA are positive for RF but negative for Anti CCP and vice versa.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample Mon through Sat 9 am; Report Same day

  • Placeholder

    RHEUMATOID AUTOIMMUNE COMPREHENSIVE PANEL

    0 out of 5

    Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. Being a systemic disease, RA can result in a variety of extra-articular manifestations. ANA’s occur both in systemic and organ specific autoimmune diseases showing positivity in Rheumatoid arthritis, Scleroderma, Sjogren’s syndrome, Mixed connective tissue disease and CREST syndrome.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    RHEUMATOID AUTOIMMUNE PANEL

    0 out of 5

    Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. Being a systemic disease, RA can result in a variety of extra-articular manifestations. ANA’s occur both in systemic and organ specific autoimmune disease showing positivity in Rheumatoid arthritis, Scleroderma, Sjogren’s syndrome, Mixed connective tissue disease and CREST syndrome.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    RHEUMATOID FACTOR (RA), SERUM

    0 out of 5

    Approximately 85% of patients with Rheumatoid arthritis have detectable RA. It may also be seen in other medical conditions like Sjogren’s syndrome and SLE.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    RHEUMATOID FACTOR (RA), SYNOVIAL FLUID

    0 out of 5

    Approximately 85% of patients with Rheumatoid arthritis have detectable RA. It may also be seen in other medical conditions like Sjogren’s syndrome and SLE.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Daily

  • Placeholder

    RHEUMATOID FACTOR, IgA

    0 out of 5

    IgA Rheumatoid factor is gaining importance as a prognostic marker in the initial stage of Chronic polyarthritis. It’s presence indicates unfavourable prognosis of the disease course.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Sat 9 am; Report Same day

  • Placeholder

    RIBOSOME P ANTIBODY, IgG

    0 out of 5

    Ribosomal P antibody is present in 5-10% of patients with Systemic Lupus Erythematosus (SLE).

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by 7th of the month; Report after 2–3 weeks

  • Placeholder

    Scl-70 (SCLERODERMA) ANTIBODY

    0 out of 5

    Scl-70 antibodies are considered to be specific for Scleroderma and are found in nearly 60% of these patients. They are more common in patients with extensive cutaneous involvement and Interstitial pulmonary fibrosis and their presence is a poor prognostic indicator.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    SJOGREN’S SYNDROME ANTIBODIES

    0 out of 5

    SSA/Ro & SSB/La are extractable nuclear antigens. SS-A/Ro antibodies occur in patients with Sjogren’s syndrome (90%), Lupus erythematosus (40-60%) & Rheumatoid arthritis. SS-B/La antibodies occur in patients with Sjogren’s syndrome (60%) &Lupus erythematosus (15%). This assay is useful for evaluating patients with signs and symptoms of connective tissue disorder in whom ANA is positive.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same Day

    • Components:

      2

  • Placeholder

    Sm (SMITH) ANTIBODY, IgG

    0 out of 5

    Smith antibodies are specific for Lupus erythematosus occuring in nearly 30%of these patients. It is a component of extractable nuclear antigens also seen in other connective tissue disorders. This assay is useful for evaluating patients with signs and symptoms of a connective tissue disorder in whom ANA is positive.

    • Pre-test Information:

      No special preparation required

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    SS-A/Ro ANTIBODY

    0 out of 5
  • Placeholder

    SS-B/La ANTIBODY

    0 out of 5

    SS-B/La is an extractable nuclear antigen with antibodies occuring in patients with Sjogren’s syndrome (60%) & Lupus erythematosus (15%). This assay is useful for evaluating patients with signs and symptoms of connective tissue disorder in whom ANA is positive.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    U1RNP ANTIBODIES

    0 out of 5

    U1RNP antibody in combination with Smith antibody provides additional support for the diagnosis of SLE. A positive U1RNP antibody alone with the corresponding clinical history supports the diagnosis of Mixed connective tissue disease.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Tue / Fri 9 am; Report Same day

  • Placeholder

    URIC ACID, SERUM

    0 out of 5

    Uric Acid is the end product of protein metabolism. High levels are seen with Gout, inherited metabolic disorders of purine metabolism, excessive purine dietary intake and increased cell turnover. Only 10-15% patients with hyperuricemia have Gout.

    • Test Type:

      Blood

    • Pre-test Information:

      No special preparation required.

    • Report Delivery:

      Daily

  • Placeholder

    VASCULITIS PANEL

    0 out of 5

    Vasculitis is characterized by inflammation and damage of blood vessels. It may be primary / sole manifestation of a disease or secondary component of another disease. It is usually immune complex mediated and is a component of several connective tissue diseases.

    • Pre-test Information:

      Overnight fasting is preferred

    • Report Delivery:

      Sample by Tue / Thu / Sat 9 am, Report Same day